BRENTUXIMAB VEDOTIN
Clinical trials for BRENTUXIMAB VEDOTIN explained in plain language.
Never miss a new study
Get alerted when new BRENTUXIMAB VEDOTIN trials appear
Sign up with your email to follow new studies for BRENTUXIMAB VEDOTIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New strategy aims to stop deadly skin cancer from coming back
Disease control Not yet recruitingThis study tests if giving the drug brentuximab vedotin as a preventive treatment after a stem cell transplant can stop an aggressive type of skin cancer (CTCL) from returning. It will involve 84 adults whose cancer had responded to prior treatments but is at high risk of relapse…
Matched conditions: BRENTUXIMAB VEDOTIN
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Targeted attack on aggressive blood cancer shows promise
Disease control Not yet recruitingThis study is testing whether adding a targeted drug called brentuximab vedotin to standard chemotherapy works better for people newly diagnosed with a specific type of lymphoma linked to the Epstein-Barr virus (EBV). Researchers want to see if this combination is safe and can he…
Matched conditions: BRENTUXIMAB VEDOTIN
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC